Miguel-Angel Perales

News Feed Opinion Blog Career Insight Dialogues Celebrities Oncolibrary
Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me
March, 2025
March 2025
M T W T F S S
 12
3456789
10111213141516
17181920212223
24252627282930
31  

Miguel-Angel Perales
Mar 4, 2025, 11:50 | Blog
Navneet Majhail: 80/20 effort to reduce REMS burden for Cell Therapy treatment centers
Navneet Majhail, Physician-in-Chief of Blood Cancers at Sarah Cannon, shared a paper Frederick L. Locke…
Feb 7, 2025, 13:15 | Blog
Roni Shouval: Treatment failure patterns in early vs late introduction of CAR T-cell therapy in large B-cell lymphoma
Roni Shouval, Assistant Attending Adult BMT and Cellular Therapy Service at MSKCC, shared on X:…
Jan 9, 2025, 17:04 | Blog
Mehdi Hamadani: Improved Patient-Reported Outcomes With Post-Transplant Cyclophosphamide
Mehdi Hamadani shared on X: "Our new BMT CTN 1703 analysis busts a few myths:…
Dec 16, 2024, 18:20 | Insight
Nektar Therapeutics Presented Phase 2 Results for NKTR-255 at ASH 2024
Proof-of-Concept Study Highlights Improved Complete Response Rates and Durability in Relapsed/Refractory Large B-Cell Lymphoma at…
Dec 11, 2024, 14:53 | Insight
Five articles suggested by Yan Leyfman
Yan Leyfman MD is the Co-founder and executive director of MedNews Week. He is also the…
Nov 28, 2024, 16:34 | Blog
Roni Shouval: Insights into Renal Injury in CAR-T Therapy from Global FDA Reports
Roni Shouval , Assistant Attending Adult BMT and Cellular Therapy Service at MSKCC, shared on…
Oct 18, 2024, 16:08 | Insight
Brandon Imber: Effective cytoreduction improves outcomes for CAR T cell patients
Brandon Imber, Radiation Oncologist at Memorial Sloan Kettering Cancer Center, posted the following on X: “Effective…
Sep 22, 2024, 04:52 | Blog
Rahul Banerjee: Why CAR-T recipients may appear to be at increased SPM risk?
Rahul Banerjee shared a post by The Cancer Letter on X, adding: "Thanks The Cancer Letter for the…
Sep 14, 2024, 17:46 | Insight
Kai Rejeski: Second Primary Malignancies following CAR T-cell therapy
Kai Rejeski shared a post on X about a recent paper by Tobias Tix et…
Sep 11, 2024, 09:23 | Insight
Myeloma Paper of the Day, September 11th, suggested by Robert Orlowski
Robert Orlowski shared on X: "Myeloma Paper of the Day: Systematic review and meta-analysis of…
Jul 30, 2024, 07:06 | Insight
Aaron Goodman: An informative paper about CD19 CART timing of complications
Aaron Goodman shared on X about a recent paper by Nausheen Ahmed et al. titled…
Jul 25, 2024, 20:13 | Insight
Optimizing the Post-CAR T Monitoring Period
Al-Ola A Abdallah, Associate Professor and Plasma Cell Disorder Program Director at Division of HMCT/University…
Jul 24, 2024, 08:12 | Insight
Meta-analysis of non-relapse mortality post-CAR-T cells in lymphoma and myeloma
Nature Medicine shared on X about a paper titled "A systematic review and meta-analysis of nonrelapse…
Jul 14, 2024, 01:25 | Insight
Piotr Wysocki: Nonrelapse mortality in CAR-T-treated patients. Beware of infections!
Piotr Wysocki recently posted on LinkedIn: "Cordas DM et al. conducted a systematic review and meta-analysis…
Jul 12, 2024, 19:08 | Insight
Interesting study - A meta-analysis of nonrelapse mortality after CAR T cell therapy
Vivek Subbiah shared on X: "Interesting study published in NatureMedicine: A systematic review and meta-analysis…
Apr 26, 2024, 20:41 | Insight
Piotr Wysocki: CAR-T therapy seems to be associated with second primary malignant neoplasms
Piotr Wysocki recently shared on LinkedIn: "In a research letter published online in JAMA Oncology,…
All: 16 Posts: 1 - 100
Special Coverage